Cargando…

Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients

BACKGROUND: Medicinal cannabis (MC) is an increasingly utilized treatment option for various refractory diseases. While robust clinical evidence supporting MC efficacy in inflammatory bowel disease (IBD) is lacking, many IBD patients report using MC to obtain symptomatic relief. Understanding this u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benson, Melissa J, Abelev, Sarah V, Connor, Susan J, Corte, Crispin J, Martin, Lewis J, Gold, Lucy K, Suraev, Anastasia S, McGregor, Iain S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Observations and Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802391/ https://www.ncbi.nlm.nih.gov/pubmed/36777301 http://dx.doi.org/10.1093/crocol/otaa015

Ejemplares similares

Attitudes and Knowledge of Australian Gastroenterologists Around the Use of Medicinal Cannabis for Inflammatory Bowel Disease
por: Benson, Melissa J, et al.
Publicado: (2020)

Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)
por: Lintzeris, Nicholas, et al.
Publicado: (2020)

Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey
por: Arkell, Thomas R., et al.
Publicado: (2023)

Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)
por: Lintzeris, Nicholas, et al.
Publicado: (2022)

Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey
por: Karanges, Emily A, et al.
Publicado: (2018)

Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey
por: Suraev, Anastasia, et al.
Publicado: (2023)

The “Next Day” Effects of Cannabis Use: A Systematic Review
por: McCartney, Danielle, et al.
Publicado: (2023)

Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing
por: Cairns, Elizabeth A., et al.
Publicado: (2023)

Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community
por: Suraev, A., et al.
Publicado: (2018)

Author Correction: Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community
por: Suraev, A., et al.
Publicado: (2018)

Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research
por: McCartney, Danielle, et al.
Publicado: (2020)

Impact of Cannabis Use on Inpatient Inflammatory Bowel Disease Outcomes in 2 States Legalizing Recreational Cannabis
por: Pusateri, Antoinette, et al.
Publicado: (2022)

Knowledge, experiences, and attitudes of Australian General Practitioners towards medicinal cannabis: a 2021–2022 survey
por: Bawa, Zeeta, et al.
Publicado: (2022)

The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
por: Arnold, Jonathon C., et al.
Publicado: (2022)

A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis
por: Bawa, Zeeta, et al.
Publicado: (2022)

Prescribing medicinal cannabis
por: Arnold, Jonathon C, et al.
Publicado: (2020)

Characterization of Staphylococcal Cassette Chromosome mec Elements from Methicillin-Resistant Staphylococcus pseudintermedius Infections in Australian Animals
por: Worthing, Kate A., et al.
Publicado: (2018)

Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
por: Swift, Wendy, et al.
Publicado: (2013)

Naturally acquired functional antibody responses to group A Streptococcus differ between major strain types
por: McGregor, Reuben, et al.
Publicado: (2023)

Risk of Uveitis in Patients With Inflammatory Bowel Disease on Immunosuppressive Drug Therapy
por: Barberio, Julie, et al.
Publicado: (2020)

An Autoimmune Protocol Diet Improves Patient-Reported Quality of Life in Inflammatory Bowel Disease
por: Chandrasekaran, Anita, et al.
Publicado: (2019)

Structural Basis of Type 2 Secretion System Engagement between the Inner and Outer Bacterial Membranes
por: Hay, Iain D., et al.
Publicado: (2017)

Tolerability of Bowel Preparation and Colonoscopy in IBD Patients: Results From a Prospective, Single-Center, Case–Control Study
por: Bezzio, Cristina, et al.
Publicado: (2020)

Effects of electroacupuncture on bladder and bowel function in patients with transverse myelitis: a prospective observational study
por: Wu, Jiani, et al.
Publicado: (2018)

Orally administered cannabidiol does not produce false‐positive tests for Δ(9)‐tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000
por: McCartney, Danielle, et al.
Publicado: (2021)

Current practice and clinicians’ perception of medication non-adherence in patients with inflammatory bowel disease: A survey of 98 clinicians
por: Soobraty, Anisah, et al.
Publicado: (2017)

Inflammatory bowel disease patient profiles are related to specific information needs: A nationwide survey
por: Daher, Saleh, et al.
Publicado: (2019)

Fecal Short-Chain Fatty Acid Concentrations Increase in Newly Paired Male Marmosets (Callithrix jacchus)
por: Zhu, Lifeng, et al.
Publicado: (2020)

Natural Transmission of Helicobacter saguini Causes Multigenerational Inflammatory Bowel Disease in C57/129 IL-10(−/−) Mice
por: Mannion, Anthony, et al.
Publicado: (2020)

Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ(9)-THC at Human CB(1) and CB(2) Receptors
por: Santiago, Marina, et al.
Publicado: (2019)

Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice
por: Gaidos, Jill K J, et al.
Publicado: (2023)

Vaccination Rates and Family Barriers Among Children with Inflammatory Bowel Disease
por: Holland, Kathleen J, et al.
Publicado: (2020)

Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial
por: McCartney, Danielle, et al.
Publicado: (2022)

Ethanolamine Influences Human Commensal Escherichia coli Growth, Gene Expression, and Competition with Enterohemorrhagic E. coli O157:H7
por: Rowley, Carol A., et al.
Publicado: (2018)

Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels
por: Heblinski, Marika, et al.
Publicado: (2020)

Case of Obstruction of the Bowels, with Remarks
Publicado: (1784)

Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease
por: Kumar, Anand, et al.
Publicado: (2020)

Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis
por: Dubinsky, Marla C, et al.
Publicado: (2022)

Simple Novel Screening Tool for Obstructive Sleep Apnea in Inflammatory Bowel Disease
por: Barnes, Alex, et al.
Publicado: (2023)

Patients’ Willingness and Perspectives Toward Chimeric Antigen Receptor T-Regulatory Cell Therapy for Inflammatory Bowel Diseases
por: Vent-Schmidt, Jens, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u5nkpjp67s7kbs30gk1dg3jjus